Login to Your Account

China Hastens to Establish Regulatory Biosimilars Framework

By Shannon Ellis
Staff Writer

Monday, August 26, 2013
SHANGHAI – Looking to lower costs and facilitate better health care outcomes, China is stepping up efforts to develop a regulatory framework and a market for biosimilars. One way or another, China has been producing biosimilars for about two decades.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription